210 related articles for article (PubMed ID: 32110810)
1. 2-phenylethynesulfonamide inhibits growth of oral squamous cell carcinoma cells by blocking the function of heat shock protein 70.
Jiang L; Xiao J
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32110810
[TBL] [Abstract][Full Text] [Related]
2. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
3. Propranolol inhibits cell viability and expression of the pro-tumorigenic proteins Akt, NF-ĸB, and VEGF in oral squamous cell carcinoma.
Shibuya CM; Tjioe KC; Oliveira SHP; Bernabé DG
Arch Oral Biol; 2022 Apr; 136():105383. PubMed ID: 35240444
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells.
Wang Y; Zhang Y; Feng X; Tian H; Fu X; Gu W; Wen Y
Oncol Rep; 2021 Mar; 45(3):1249-1260. PubMed ID: 33650651
[TBL] [Abstract][Full Text] [Related]
5. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
Wang M; Feng Z; Li X; Sun S; Lu L
Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
[TBL] [Abstract][Full Text] [Related]
6. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
[TBL] [Abstract][Full Text] [Related]
7. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
Zhu R; Mao Y; Xu X; Li Y; Zheng J
Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
9. The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70.
Wang H; Bu L; Wang C; Zhang Y; Zhou H; Zhang X; Guo W; Long C; Guo D; Sun X
Cell Death Dis; 2018 Jun; 9(7):734. PubMed ID: 29959331
[TBL] [Abstract][Full Text] [Related]
10. Heat Shock Proteins 70 Regulate Cell Motility and Invadopodia-Associated Proteins Expression in Oral Squamous Cell Carcinoma.
Ding LX; Zhang J; Yang SS; Wu J; Su T; Wang WM
Front Endocrinol (Lausanne); 2022; 13():890218. PubMed ID: 35957827
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa exotoxin A reduces chemoresistance of oral squamous carcinoma cell via inhibition of heat shock proteins 70 (HSP70).
Park SR; Lee KD; Kim UK; Gil YG; Oh KS; Park BS; Kim GC
Yonsei Med J; 2010 Sep; 51(5):708-16. PubMed ID: 20635445
[TBL] [Abstract][Full Text] [Related]
12. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.
Gao L; Dong J; Zhang N; Le Z; Ren W; Li S; Li F; Song J; Wang Q; Dou Z; Park SY; Zhi K
Anticancer Agents Med Chem; 2019; 19(2):248-255. PubMed ID: 30378503
[TBL] [Abstract][Full Text] [Related]
14. Cordycepin Enhances Radiosensitivity in Oral Squamous Carcinoma Cells by Inducing Autophagy and Apoptosis Through Cell Cycle Arrest.
Ho SY; Wu WS; Lin LC; Wu YH; Chiu HW; Yeh YL; Huang BM; Wang YJ
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661901
[TBL] [Abstract][Full Text] [Related]
15. The upregulation of heat shock protein 70 expression in areca quid chewing-associated oral squamous cell carcinomas.
Lee SS; Tsai CH; Ho YC; Chang YC
Oral Oncol; 2008 Sep; 44(9):884-90. PubMed ID: 18234541
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
Lee JC; Chung LC; Chen YJ; Feng TH; Chen WT; Juang HH
Cancer Lett; 2015 May; 360(2):310-8. PubMed ID: 25721086
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
Wang Q; Zhang X; Song X; Zhang L
Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
[TBL] [Abstract][Full Text] [Related]
18. LINC00961 suppresses cell proliferation and induces cell apoptosis in oral squamous cell carcinoma.
Pan LN; Sun YR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3358-3365. PubMed ID: 31081090
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
[TBL] [Abstract][Full Text] [Related]
20. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
Sento S; Sasabe E; Yamamoto T
PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
